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doi:10.1016/j.kjms.2010.03.001Abstract The aim of the present study was to evaluate the effects of phosphodiesterase 5
inhibitors on renal tubular apoptosis and also on expressions of endothelial and inducible nitric
oxide synthases (eNOS and iNOS) in the ipsilateral kidney after partial unilateral ureteral
obstruction (PUUO) in a rat model. Forty Wistar albino rats were divided into five groups. In
Groups 1e4, left experimental PUUO was created. Sildenafil, vardenafil, and tadalafil were
administrated to the rats of Groups 2e4, respectively. The pills were orally given to the rats
for 30 days. Group 5 was defined as sham. After 30 days, all rats were sacrificed, and nephrec-
tomy was performed. The renal specimens were examined histopathologically. Left hydroure-
teronephrosis was observed in Groups 1e4. Mean apoptotic cell count and eNOS and iNOS
levels were significantly increased in Group 1 when compared with the other groups. The rats
in Groups 2e4 showed significantly decreased apoptotic cell count and eNOS and iNOS values in
the renal tubular tissue in accordance with Group 1 (p< 0.05). There were significant differ-
ences in apoptotic cell counts between sildenafil group and the other two study groups. The
sildenafil group demonstrated lesser apoptotic cell count than the vardenafil (pZ 0.021)
and tadalafil (pZ 0.009) groups. PUUO increases the renal tubular apoptosis and elevates
NOS concentrations in renal tubular tissue after PUUO. Phosphodiesterase 5 inhibitors have
a protective effect against the tubular apoptosis.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Barlas Arinnapark Sitesi NO:2/A/24 C¸ayyolu, Ankara, Turkey.
.com (E. Huri).
vier Taiwan LLC. All rights reserved.
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Partial ureteral obstruction (PUUO) is one of the most
common problems in urological practice. It has been
demonstrated that urinary tract obstruction induces
progressive apoptosis of both renal tubular and interstitial
cells [1]. Tubular cell apoptosis is known as a major factor
for the progressive renal tissue loss in obstructive uropathy.
Nitric oxide (NO) is shown to be produced in acute
unilateral ureter obstruction and is known to modify renal
hemodynamics in the early phase of the obstruction [2].
This substance functions as an antifibrotic factor in the
chronic phase of UUO [3]. NO synthase (NOS), the enzyme
responsible for the production of NO, has three major iso-
forms, namely, neuronal, endothelial, and inducible NOS.
Although endothelial NOS (eNOS) is Ca2þ dependent and is
expressed in many tissues, including testes, inducible NOS
(iNOS) is Ca2þ independent and is induced in tissues after
exposure to inflammatory cytokines or ischemia [4].
Sildenafil citrate, vardenafil HCl, and tadalafil are widely
used as primary treatment methods of erectile dysfunction
(ED). These are phosphodiesterase (PDE) 5 inhibitors and
enhance cyclic guanosine monophosphate and NO-medi-
ated vasodilatation with resulting improvement of ED [5].
Although these drugs had been developed for ED, they
became one of the most commonly prescribed pharma-
ceuticals. The relationship between PDE5 inhibitors and
apoptosis was also reported. Sildenafil has been recently
shown to have a strong protective effect against apoptosis
through a NO signaling pathway [6]. The aim of the present
study was to evaluate the effects of sildenafil citrate,
vardenafil HCl, and tadalafil on renal tubular apoptosis and
also on expressions of eNOS and iNOS in rat PUUO model.
Patients and methods
The experimental study was carried out after obtaining the
approval of the local Ethics Committee. Forty Wistar albino
rats (220e250 g) were enrolled. All surgical interventions
were performed under sterile conditions by the same
surgical team at the same period and environment. The rats
were randomly assigned into five experimental groups. The
groups were classified as followsdGroup 1 (nZ 8): PUUO;
Group 2 (nZ 8): PUUOþ sildenafil tablet (Viagra, 1 mg/d;
Pfizer, NY, USA); Group 3 (nZ 8): PUUOþ vardenafil tablet
(Levitra, 0.5 mg/d; Bayer, Leverkusen, Germany); Group 4
(nZ 8): PUUOþ tadalafil tablet (Cialis, 10 mg/72 h; Lilly,
Indianapolis, Indiana, USA); and Group 5 (nZ 8): sham.
The pills were diluted with 10-cc distilled water to form
a homogeneous solution and administered to rats for 30
days, orally. The approximate dosages of PDE5 inhibitors,
which have been reported previously, were applied [7,8].
Group 5 was defined as sham.
Animal preparation and surgical procedures
After the starvation period of 12 hours, ceftriaxone (20 mg/
kg, intramuscularly) was administered as a prophylactic
dose 1 hour before the procedure. The rats were placed in
supine position after general anesthesia (ketamine, 50 mg/
kg, intramuscularly). The abdominal skin was cleaned andshaved. Laparotomy was performed, and the left ureter
was isolated. In Groups 1e4, experimental PUUO was
created by placing an intravenous catheter into the ureter
lumen and by ligating the ureter and catheter together by
using 4e0 silk suture. By ligating over the catheter, the
ureters had been narrowed surgically. The catheter was
then removed cautiously as to not injure the ureter, and
the surgical incision was closed. In sham group, ureters
were just manipulated.
The rats were housed in individual cages in a tempera-
ture (22e24C), humidity (50e55%), and light/dark cycle
controlled room (12/12 h of light and dark) after they had
recovered from the general anesthesia. They had free
access to food and water, and water was changed daily.
They were observed to urinate normally on the same day
and feed normally during 30 days.
After 30 days, all rats were sacrificed by an excessive
dose of pentobarbital sodium (100 mg/kg, intraperitone-
ally), and unilateral nephrectomy was carried out. The
nephrectomy materials of all the groups were placed
separately in 10% formalin.
Histopathological evaluation
All renal specimens were kept at 4C and then embedded in
paraffin blocks. The specimens were then deparaffinized,
rehydrated, and sectioned at 5 mm. The sections were
microwave pretreated in 10 mM citrate buffer for 20minutes
and were cooled at room temperature for 20 minutes.
Afterwards, the sections were washed with buffer solution
for 10 minutes. Renal apoptosis was evaluated by using the
Apoptosis Protease Activating Factor (Apaf-1) kit (Lab Vision
Corp., Neomarkers, CA, USA) for color development. iNOS
and eNOS expressions were evaluated by using iNOS Ab-1 and
eNOS Ab-1 antibodies (Lab Vision Corp.), respectively. For
each group, the number of apoptotic cells and expressions of
eNOS and iNOS were calculated by counting positive stained
cells in a randomized tissue section with 40magnification.
Statistical analysis
The statistical data were analyzed using Statistical Package
for the Social Sciences (SPSS, Chicago, IL, USA) Version 13.0
for Windows. All values were expressed as mean standard
deviation. The differences among the groups were
compared by one-way analysis of variance and post hoc
Tukey tests. A p value less than 0.05 was considered to
indicate statistical significance.
Results
Left hydroureteronephrosis was observed in Groups 1e4.
Mortality was not observed either in the preoperative
period or in the postoperative 30 days. The complications,
such as infection, allergic reaction, urination problems, and
urinary retention, were not observed in any of the groups.
Microscopic findings were used to compare the groups.
PUUO caused significant increases in tubular cell
apoptosis, eNOS, and iNOS.Mean apoptotic cell count (Fig. 1)
and eNOS and iNOS levels were significantly increased in
Group 1 according to the other groups (Table 1).
Figure 1. (A) In partial ureteral obstruction (PUUO) group (Group 1), apoptotic cells are markedly increased in renal tubular
tissue (immunohistochemical stained method) (40). (B) The difference of apoptotic cells in PUUOþ sildenafil group (Group 2).
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eNOS, and iNOS were significantly decreased (Fig. 2) when
compared with those of Group 1 (p< 0.05) (Table 1).
There were significant differences between sildenafil
group and the other PDE5 inhibitoreapplied groups in terms
of mean apoptotic cell count. The sildenafil group demon-
strated less apoptotic cell expression than the vardenafil
(pZ 0.021) and tadalafil (pZ 0.009) groups. However, this
difference was not observed in eNOS and iNOS expressions.Discussion
Tubulointerstitial fibrosis and apoptosis are the two major
pathological pathways in obstructive nephropathy.
Apoptosis and necrosis occur after ischemiaereperfusion
injury [9]. Apoptosis, caused by low-grade injury insuffi-
cient to lead to necrosis, has been described in tubules
after PUUO and renal ischemia [10,11]. Tubular cell
apoptosis is an early event that occurs before the onset of
frank fibrosis. As we know from the literature, mechanical
stretching of tubular cells provides a major stimulus for
apoptosis [12].
The mechanism of the pathophysiological changes in
PUUO is not well known. Renal blood flow impairment,
intrapelvic pressure elevation, and vasoactive and inflam-
matory mediators are some of the known factors in path-
ophysiology of renal obstructive parenchymal injury [13].Table 1 Comparison of the groups according to histopathologic
Histopathological parameters Group 1 (partial
ureteral obstruction)
Apoptotic cellsa 14.12 0.99
Endothelial nitric oxide synthaseb 2.62 0.51
Inducible nitric oxide synthasec 2.75 0.46
a pZ 0.0001 for Group 1 vs. Group 2; pZ 0.0001 for Group 1 vs. Grou
Group 3; and pZ 0.009 for Group 2 vs. Group 4.
b pZ 0.005 for Group 1 vs. Group 2; pZ 0.001 for Group 1 vs. Group
Group 5.
c pZ 0.003 for Group 1 vs. Group 2; pZ 0.001 for Group 1 vs. Group
Group 5.
p< 0.05 by one-way analysis of variance and Tukey tests.Additionally, reactive oxygen species are thought to play an
important role in tubulointerstitial inflammation associated
with obstructive nephropathy [10,14]. Previous studies
have highlighted the importance of apoptosis after
complete ureteral obstruction and PUUO. A well-estab-
lished model of partial unilateral ureteral obstruction in the
weanling rat kidney was used to investigate the role of
renal tubular apoptosis during hydronephrotic state asso-
ciated with partial obstruction. The result of this study
indicates that apoptosis occurs during the PUUO in
a manner similar to that observed in complete ureteral
obstruction [15].
The expression of iNOS in the kidney occurs spontaneously
[16,17]. The source of NO and its production have not been
well characterized. Moreover, the role of NO in renal injury
still remains controversial. Both proapoptotic and anti-
apoptotic effects of NO have been demonstrated so far [18].
NO can be either toxic or protective, depending on the situ-
ation. In the kidney, many types of cells are capable of
secreting NO. However, the changes in intrarenal pressure
accompanying UUO could result in the activation of tubular
NOS [19]. Miyajima et al. [20] have previously confirmed NO
production in renal tubular epithelial cells exposed to
mechanical stretch. In this study, the expressions of eNOS
and iNOS in the renal tubular system were significantly
increased in PUUO group in accordance with the sham group.
PDE5 is shown to be widely distributed in the smooth
muscles of vessels and internal organs, the striatedal parameters
Group 2
(sildenafil)
Group 3
(vardenafil)
Group 4
(tadalafil)
Group 5
(sham)
5.37 0.74 6.62 0.51 6.75 0.88 6.87 0.64
1.75 0.46 1.62 0.51 1.75 0.46 1.87 0.35
1.87 0.35 1.75 0.46 1.87 0.64 2
p 3; pZ 0.0001 for Group 1 vs. Group 4; pZ 0.021 for Group 2 vs.
3; pZ 0.005 for Group 1 vs. Group 4; and pZ 0.022 for Group 1 vs.
3; pZ 0.003 for Group 1 vs. Group 4; and pZ 0.013 for Group 1 vs.
Figure 2. (A) Endothelial nitric oxide synthase (eNOS) expression in Group 2 and (B) inducible nitric oxide synthase (iNOS)
expression in Group 3 were significantly decreased compared with those in Group 1. (C) eNOS and (D) iNOS (immunohistochemical
stained method 40).
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relaxation. PDE5 inhibitors also increase NO level in tissue
through PDE5 inhibition. Many of the biological actions of
NO are mediated by cyclic 3’5’ guanosine monophosphate,
which is rapidly degraded by PDEs [21]. Thus inhibiting PDEs
elevates NO level in the tissue. In this study, we observed
significant decreases of mean NOS levels in the renal
tubular tissue after PDE5 inhibitor administration. In our
opinion, this reduction is probably the result of the
suppression of the elevated NO level in renal tissue. There
are also some reports suggesting that sildenafil and other
PDE5 inhibitors may have anti-inflammatory properties
through inhibition of reactive oxygen species [22,23]. This
effect can also explain the favorable findings obtained with
the use of PDE5 inhibitors in this study.
The antiapoptotic properties of PDE5 inhibitors are still
not well known. The antiapoptotic effect of PDE5 inhibitors
was the main finding in our study. The possible mechanism
of antiapoptotic effect of PDE5 inhibitors can be explained
with sildenafil model. In different experimental studies, it
has been suggested that the administration of sildenafil
could result in opening of the mitochondrial adenosine
triphospate (ATP)-sensitive potassium (mitoKATP) channels
either directly or through a variety of signaling pathways,
such as activation of protein kinase C and mitogen-acti-
vated protein kinases [24]. It has been shown that sildenafil
may inhibit apoptosis by NO-mediated upregulation of Bcl-
2/Bax ratio and attenuation of cytochrome C release [24].
Another finding in our study was the difference in affec-
tivity of PDE5 inhibitors on tubular apoptosis. Although there
were no differences between vardenafil and tadalafil groups,
the mean apoptotic cell count was significantly decreased in
the sildenafil group. Aswe know from the literature, PDE5 and
PDE11arecommonly found inthekidneys, and tadalafil ismore
selective for PDE11 than sildenafil and vardenafil [25].
Therefore, itwould not be a surprise to expectmore favorable
effects in the tadalafil group. Therefore, the additional
improvingeffectof sildenafilmaybeexplainedwithaprobable
stronger antiapoptotic effect of this drug. However, we could
not evaluate the apoptosis with cell culture or morebiomarkers because of the technical properties of our
pathology laboratory; hence, it could be the restrictive factor
of this study.
In conclusion, our findings demonstrate that PUUO
increases renal tubular cell apoptosis and elevates NOS
concentrations in renal tubular tissues after PUUO. PDE5
inhibitors, which are known to be effective in ED treat-
ment, have a protective effect against the tubular
apoptosis. In our opinion, these findings may be important
in some clinical conditions, such as ureteral stones. Our
findings that will be supported with the additional experi-
mental studies may help physicians to use PDE5 inhibitors in
the treatment of PUUO-related clinical conditions.
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